Antimicrobial Resistance - Novel coalition sets out to tackle the next global health crisis
A diverse range of sectors and industries come together in partnership to address infection management, advocating a whole system approach
After the uncomfortably close encounter with COVID-19, concerns are rising that antibiotic resistant infections are already presenting the next global health crisis.
In a bid to tackle this 'hidden pandemic', the Infection Management Coalition (IMC) has launched their whitepaper outlining a call for transformational change in the way infection is detected, monitored, prevented, and managed across the NHS, healthcare systems and broader society, by adopting a whole system approach.
The coalition, which comprises partners spanning pharmaceuticals, MedTech and diagnostics, originally came together in January last year to to drive change in support of holistic management and pandemic preparedness in response to the impact the COVID-19 pandemic has had on societies and economies globally.
“Antimicrobial resistance is a growing challenge and an existential threat that we must overcome,” commented Dr David Jenkins, President of the British Society for Antimicrobial Chemotherapy.
The whitepaper, which offers a blueprint for further collaboration, calls for the creation of a "resilient" and "mature" healthcare system with a focus on outbreak and pandemic preparedness, infection prevention, rapid treatment of time-critical viral and bacterial infection, enabling it to ultimately deliver effective antimicrobial stewardship.
Specifically, it includes "tangible recommendations" which break down the siloes within the sector, and identifies owners, timelines, and required actions.
As a next step, the IMC is calling for the development of a cohesive policy to support action, warning that a lack of measures now could result in a pandemic that will have a far greater impact than that seen with COVID-19.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance